Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia

ABSTRACT: Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia

PROVIDER: PRJNA951775 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24055600.fastq.gz	Fastqsanger.gz
	SRR24055601.fastq.gz	Fastqsanger.gz
	SRR24055602.fastq.gz	Fastqsanger.gz
	SRR24055603.fastq.gz	Fastqsanger.gz
	SRR24055604.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 60

Similar Datasets

Plasma exosomes lncRNA-miRNA-mRNA network construction and its diagnostic efficacy identification in first-episode schizophrenia

Project description:This study examined the miRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia. This study examined the lncRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia. This study examined the mRNA expression level in exosomal derived from the plasma of first episode schizophrenia (FOS) patients and Healthy controls (HC), and explored the the potential of exosomes as biomarkers for schizophrenia.

2023-08-30 | GSE228881 | GEO

The Multiomics Landscape of Plasma Exosomes in First-Episode Drug-Naïve of Schizophrenia

Project description:This research project aims to explore the multiomics landscape of plasma exosomes in patients with schizophrenia. Our study involves 10 first-episode drug-naïve schizophrenia patients and 10 healthy controls. By comparing the exosomes derived from these two groups, we hope to uncover biomarkers associated with schizophrenia and potential pathogenic mechanisms. The project seeks to provide new insights for the early diagnosis and intervention of schizophrenia.

2025-08-25 | PXD061889 | Pride

The Multiomics Landscape of Plasma Exosomes in First-Episode Drug-Naïve of Schizophrenia

Project description:Background: Schizophrenia (SZ) is a debilitating mental illness with uncertain etiology and challenges in early diagnosis and treatment outcomes. For the first time, we applied a multiomics techniques to explore plasma exosomal markers of SZ and underlying molecular mechanisms. Methods: Exosomes were separated and identified from ten drug-naive first-episode SZ patients and ten healthy controls. Then small RNA-seq and high-performance liquid chromatography-tandem mass spectrometry technology were used to detect the profiles of microRNAs (miRNAs) and proteomics, respectively. The integrative multiomics analysis was further performed. Results: A total of 167 differentially expressed miRNAs (DE miRNAs) were identiﬁed in plasma exosomes from drug-naive first-episode SZ patients. The potential target genes of DE miRNAs were predicted, and GO and KEGG enrichment analysis showed that they were associated with RNA catabolic process, proteasome-mediated ubiquitin-dependent protein catabolic process, etc. Proteomic analysis identified 274 differentially expressed proteins (DEPs), and DEPs were mainly enriched in immune response and some signaling pathways. The combination of Top 10 DE miRNAs/ DEPs both had good values to diagnose SZ. Importantly, miRNA-protein ceRNA networks were constructed by integrating multiomics, one consisting of 21 downregulated DE miRNAs and 21 upregulated DEPs and the other consisting of 64 upregulated DE miRNAs and 86 downregulated DEPs in SZ patients. Conclusions: Our study for the ﬁrst time describes the multiomics landscape of plasma exosomes in first-episode drug-naïve of SZ, and provides novel insights into the molecular alterations of SZ. These findings hold promise for advancing diagnostic and therapeutic strategies in SZ management.

2025-08-13 | GSE292347 | GEO

Peripheral mRNA expression of first-episode drug-naïve patients with schizophrenia

Project description:Schizophrenia is a complex mental disorder. Accurate diagnosis and classification of schizophrenia has always been a major challenge in clinic due to the lack of biomarkers. Therefore, identifying molecular biomarkers, particularly in the peripheral blood, is of great significance. This study aimed to identify immune-related molecular biomarkers of schizophrenia in peripheral blood. Eighty-four Peripheral blood leukocytes of first-episode drug-naïve (FEDN) patients with schizophrenia and 97 healthy controls were collected and examined using high-throughput RNA-sequencing. Differentially-expressed genes (DEGs) were analysed. Weighted correlation network analysis (WGCNA) was employed to identify schizophrenia-associated module genes. The CIBERSORT algorithm was adopted to analyse immune cell proportions. Then, machine-learning algorithms including random forest, LASSO, and SVM-RFE were employed to screen immune-related predictive genes of schizophrenia. The RNA-seq analyses revealed 734 DEGs. Further machine-learning-based bioinformatic analyses screened out three immune-related predictive genes of schizophrenia (FOSB, NUP43, and H3C1), all of which were correlated with neutrophils and natural killer cells resting.

2025-02-28 | GSE243841 | GEO

Blood methylomes of the first-episode schizophrenia patients differing in their response to amisulpride treatment (OPTiMiSE cohort)

Project description:Blood methylomes of the first-episode schizophrenia patients differing in their response to amisulpride treatment (OPTiMiSE cohort)

2024-12-30 | E-MTAB-13006 | biostudies-arrayexpress

Blood DNA methylation profiles from schizophrenia cases, first episode psychosis patients and controls II

Project description:Genome-wide patterns of DNA methylation were quantified using the Illumina Infinium HumanMethylation450K BeadChip (“450K array”) in DNA samples isolated from blood for schizophrenia cases, first episode psychosis patients and controls. These samples were profiled as part of a wider study where they were meta-analysed with other cohorts.

2021-04-07 | GSE152027 | GEO

Expression data from cohort of remitted first-episode schizophrenia patients with less than 5 years of evolution

Project description:To explore the genomic architecture of schizophrenia symptomatology, we analysed blood co-expression modules, i.e. clusters of genes with highly correlated expression, in a cohort of remitted first-episode schizophrenia patients with less than 5 years of evolution, and their association with clinical data, including global functioning, clinical symptomatology and premorbid adjustment.

2022-01-18 | GSE193818 | GEO

First-episode schizophrenia whole blood bulk RNAseq

Project description:Bulk mRNA-sequencing of whole blood samples of first-episode schizophrenia patients and healthy controls

| PRJEB53454 | ENA

The Multiomics Landscape of Plasma Exosomes in First-Episode Drug-Naïve of Schizophrenia

Project description:The Multiomics Landscape of Plasma Exosomes in First-Episode Drug-Naïve of Schizophrenia

| PRJNA1238206 | ENA

Peripheral mRNA expression of first-episode drug-naïve patients with schizophrenia

Project description:Peripheral mRNA expression of first-episode drug-naïve patients with schizophrenia

| PRJNA1020139 | ENA